Ariana Saatchi1, Fawziah Marra2. 1. Faculty of Pharmaceutical Sciences, University of British Columbia, 2405 Wesbrook Mall, Vancouver, BC, V6T 1Z3, Canada. 2. Faculty of Pharmaceutical Sciences, University of British Columbia, 2405 Wesbrook Mall, Vancouver, BC, V6T 1Z3, Canada. fawziah@mail.ubc.ca.
Abstract
OBJECTIVES: Antibiotic prescribing in paediatric care is highly prevalent, and quite often, children are prescribed for conditions, like upper respiratory tract infections, which are self-limiting and viral in aetiology. The purpose of this study was to identify potential new targets for provincial antimicrobial stewardship efforts. METHODS: Antibiotic prescription data for children were extracted from a provincial prescription database, linked to physician billing data in order to obtain diagnostic information, and then combined with demographic data in order to obtain patient age, sex and geographic location. Prescription rates were calculated, and trends were examined by major anatomical therapeutic chemical (ATC) classification. RESULTS: Our cohort included an average of 271,134 children per year and 1,767,652 antibiotic prescriptions. Antibiotic utilization increased 4.5% (from 453 to 474 prescriptions per 1000 population). The greatest increases in prescribing were seen in children aged 0-2 years. Increased indication-specific rates of prescribing were observed in children aged 0-2 years, across every category. Although antibiotic use for upper respiratory tract infections decreased, prescribing rates remain as high as 5 times more than other indications. CONCLUSION: Past studies have widely illustrated decreasing or static rates of prescribing in British Columbia. However, these results signal a potential problem in the sphere of paediatric antibiotic prescribing, wherein rates have been increasing since 2013. Despite the success of provincial efforts in reducing the use of broad-spectrum penicillins, marked surges in the use of classes like tetracyclines, quinolones and other antibacterials identify a new potential target for provincial stewardship.
OBJECTIVES: Antibiotic prescribing in paediatric care is highly prevalent, and quite often, children are prescribed for conditions, like upper respiratory tract infections, which are self-limiting and viral in aetiology. The purpose of this study was to identify potential new targets for provincial antimicrobial stewardship efforts. METHODS: Antibiotic prescription data for children were extracted from a provincial prescription database, linked to physician billing data in order to obtain diagnostic information, and then combined with demographic data in order to obtain patient age, sex and geographic location. Prescription rates were calculated, and trends were examined by major anatomical therapeutic chemical (ATC) classification. RESULTS: Our cohort included an average of 271,134 children per year and 1,767,652 antibiotic prescriptions. Antibiotic utilization increased 4.5% (from 453 to 474 prescriptions per 1000 population). The greatest increases in prescribing were seen in children aged 0-2 years. Increased indication-specific rates of prescribing were observed in children aged 0-2 years, across every category. Although antibiotic use for upper respiratory tract infections decreased, prescribing rates remain as high as 5 times more than other indications. CONCLUSION: Past studies have widely illustrated decreasing or static rates of prescribing in British Columbia. However, these results signal a potential problem in the sphere of paediatric antibiotic prescribing, wherein rates have been increasing since 2013. Despite the success of provincial efforts in reducing the use of broad-spectrum penicillins, marked surges in the use of classes like tetracyclines, quinolones and other antibacterials identify a new potential target for provincial stewardship.
Authors: Katherine E Fleming-Dutra; Alicia Demirjian; Monina Bartoces; Rebecca M Roberts; Thomas H Taylor; Lauri A Hicks Journal: Pediatr Infect Dis J Date: 2018-01 Impact factor: 2.129
Authors: Sandra de Bie; Florentia Kaguelidou; Katia M C Verhamme; Maria De Ridder; Gino Picelli; Sabine M J M Straus; Carlo Giaquinto; Bruno H Stricker; Julia Bielicki; Mike Sharland; Miriam C J M Sturkenboom Journal: Pediatr Infect Dis J Date: 2016-12 Impact factor: 2.129
Authors: Katherine E Fleming-Dutra; Adam L Hersh; Daniel J Shapiro; Monina Bartoces; Eva A Enns; Thomas M File; Jonathan A Finkelstein; Jeffrey S Gerber; David Y Hyun; Jeffrey A Linder; Ruth Lynfield; David J Margolis; Larissa S May; Daniel Merenstein; Joshua P Metlay; Jason G Newland; Jay F Piccirillo; Rebecca M Roberts; Guillermo V Sanchez; Katie J Suda; Ann Thomas; Teri Moser Woo; Rachel M Zetts; Lauri A Hicks Journal: JAMA Date: 2016-05-03 Impact factor: 56.272
Authors: Megan Rose Williams; Giles Greene; Gurudutt Naik; Kathryn Hughes; Christopher C Butler; Alastair D Hay Journal: Br J Gen Pract Date: 2018-01-15 Impact factor: 5.386
Authors: Eefje G P M de Bont; Inge H M van Loo; Nicole H T M Dukers-Muijrers; Christian J P A Hoebe; Catharina A Bruggeman; Geert-Jan Dinant; Jochen W L Cals Journal: Arch Dis Child Date: 2012-12-25 Impact factor: 3.791
Authors: Harriet Downing; Emma Thomas-Jones; Micaela Gal; Cherry-Ann Waldron; Jonathan Sterne; William Hollingworth; Kerenza Hood; Brendan Delaney; Paul Little; Robin Howe; Mandy Wootton; Alastair Macgowan; Christopher C Butler; Alastair D Hay Journal: BMC Infect Dis Date: 2012-07-19 Impact factor: 3.090
Authors: Abdullah A Mamun; Ariana Saatchi; Max Xie; Hannah Lishman; Edith Blondel-Hill; Fawziah Marra; David M Patrick Journal: Open Forum Infect Dis Date: 2021-04-13 Impact factor: 3.835